AACR22: As post-Covid development takes shape, BioNTech reports first human data for CAR-T/cancer vaccine combo
NEW ORLEANS — Continuing to push into new frontiers following the huge success of its Covid-19 vaccine, BioNTech revealed the first-in-human data for its combination …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.